Get the Stockscreener App
2.84
67.35%
1.14
Vivosim Labs Inc stock is traded at $2.84, with a volume of 57.50M.
It is up +67.35% in the last 24 hours and up +56.32% over the past month.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
See More
Previous Close:
$1.70
Open:
$2.95
24h Volume:
57.50M
Relative Volume:
41.03
Market Cap:
$7.28M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+49.74%
1M Performance:
+56.32%
6M Performance:
+41.54%
1Y Performance:
+0.00%
1-Day Range:
$2.6401
$3.40
1-Week Range:
$1.70
$3.40
52-Week Range:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Name
Vivosim Labs Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
2.7909 | 4.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.87 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.09 | 78.77B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
835.70 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
342.33 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
342.54 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Vivosim Labs Inc Stock (VIVS) Latest News
VivoSim Labs stock (VIVS) jumps premarket after Korea, China distributor deals — what to watch next - TechStock²
VivoSim Expands Asia-Pacific Access To NAMKind Toxicology Services; Stock Skyrockets - Nasdaq
Aug Gainers: Will VivoSim Labs Inc benefit from AI trendsMarket Risk Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based - GlobeNewswire
Layoff Watch: What is the implied volatility of CNEYJuly 2025 Intraday Action & Technical Pattern Alert System - baoquankhu1.vn
Portfolio Shifts: Will Barnwell Industries Inc benefit from green energy policiesJuly 2025 PostEarnings & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Breakout Zone: Whats the analyst consensus on TruBridge IncPortfolio Return Summary & Fast Moving Market Watchlists - baoquankhu1.vn
Will VivoSim Labs Inc. stock gain from strong economy2025 Growth vs Value & Real-Time Buy Signal Notifications - bollywoodhelpline.com
Trend Review: Is VivoSim Labs Inc a stock for growth or value investorsJuly 2025 WrapUp & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Swings: Is VivoSim Labs Inc stock forming a triangle pattern2025 Risk Factors & Weekly Stock Breakout Alerts - baoquankhu1.vn
Guidance Update: Is VivoSim Labs Inc stock forming a triangle patternWeekly Risk Report & Stepwise Trade Execution Plans - baoquankhu1.vn
Aug EndMonth: What chart patterns are forming on VivoSim Labs IncJuly 2025 Retail & Capital Efficient Trade Techniques - baoquankhu1.vn
CEO Change: Will VivoSim Labs Inc benefit from AI trendsMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
VivoSim Labs, Inc.Common Stock (NQ: VIVS - FinancialContent
Why VivoSim Labs Inc. stock is favored by pension fundsJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - Улправда
Is VivoSim Labs Inc. (4OR) stock prepared for digital transition2025 Historical Comparison & Fast Entry and Exit Trade Plans - Улправда
How VivoSim Labs Inc. stock compares to market leadersWeekly Profit Summary & High Accuracy Investment Signals - Улправда
Can VivoSim Labs Inc. stock deliver surprise earnings beatJuly 2025 Spike Watch & Smart Allocation Stock Reports - Улправда
EPL Limited Price Holds Above Key Fib LevelShort-Term Trading Alerts & Fast Profit Trading Tips - bollywoodhelpline.com
Is VivoSim Labs Inc. (4OR) stock a top dividend aristocrat candidateRisk Adjusted Returns & Stay Ahead With Daily Market Discussions - Улправда
VivoSim Labs appoints Amar Sethi as chief scientific officer By Investing.com - Investing.com Nigeria
Why VivoSim Labs Inc. stock could outperform in 20252026 world cup usa national team round of 16 playmakers set piece tactics expert forecast statistical analysis - ulpravda.ru
Is VivoSim Labs Inc. stock affected by interest rate hikes2026 world cup usa national team semifinals defensive leaders high defensive line winner prediction preview - Улправда
VIVS Insider Trading - Quiver Quantitative
VivoSim Labs appoints Amar Sethi, M.D., Ph.D. as chief scientific officer - marketscreener.com
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer - The Manila Times
VivoSim Labs appoints Amar Sethi as chief scientific officer - Investing.com
Is VivoSim Labs Inc. stock positioned for long term growth2026 world cup usa national team group stage top scorers high defensive line tactical prediction statistical analysis - ulpravda.ru
Target’s SoHo Store Opens Amid Strategic Expansion Efforts - StocksToTrade
VivoSim Labs (NASDAQ:VIVS) Shares Up 2.6% – Should You Buy? - Defense World
Merger Talk: Why retail investors favor VivoSim Labs Inc. stockMarket Rally & Technical Analysis for Trade Confirmation - Улправда
Why retail investors favor VivoSim Labs Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - Улправда
Earnings Update: Why retail investors favor VivoSim Labs Inc. stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - Улправда
US Stocks Recap: Why VivoSim Labs Inc. stock could outperform in 2025Day Trade & Verified Technical Trade Signals - Улправда
Amar Akhtar Sethi Net Worth (2025) - GuruFocus
Trade Recap: Will VivoSim Labs Inc. stock benefit from automationGlobal Markets & High Win Rate Trade Tips - ulpravda.ru
Buyback Watch: Is VivoSim Labs Inc. stock attractive after correctionWeekly Market Report & Stepwise Entry/Exit Trade Alerts - Улправда
VivoSim Labs Stockholders Approve Directors and Governance Matters - TipRanks
Is VivoSim Labs Inc. stock undervalued vs historical averagesJuly 2025 Selloffs & Free Growth Oriented Trading Recommendations - Улправда
Will VivoSim Labs Inc. stock benefit from automationPortfolio Value Summary & Verified Entry Point Detection - Улправда
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser
How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser
Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser
Vivosim Labs Inc Stock (VIVS) Financials Data
There is no financial data for Vivosim Labs Inc (VIVS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.25%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):